Search results
Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust...
The Economic Times· 11 hours agoShark Tank fame Namita Thapar took to social media to share an emotional note following the listing...
Emcure Pharmace Share Price, Emcure Pharmace Stock Price, Emcure Pharmaceuticals Ltd. Stock Price,...
CNBC Awaaz· 18 hours agoEmcure Pharmace Share Price: Find the latest news on Emcure Pharmace Stock Price. Get all the information on Emcure Pharmace with historic price charts for NSE / BSE. Experts & Broker view also ...
Ambey Laboratories makes robust debut with 25% premium on NSE SME
CNBC Awaaz· 21 hours agoShares of Ambey Laboratories made a positive start to its stock market.The Rs 44.68-crore public...
Namita Thapar in emotional X post congratulates Emcure Pharma team on 31% premium listing, , quotes...
Livemint· 1 day agoEmcure Pharmaceuticals’ stock opened at ₹1,325.05, up 31.45 per cent on both the BSE and the NSE on...
Emcure Pharma: Shark Tank India fame Namita Thapar’s company shares make a strong debut; writes...
The Times of India· 2 days agoNamita Thapar’s Emcure Pharmaceuticals shares made a robust debut on July 10, listing at Rs...
Emcure Pharma closes 3% higher after making strong market debut; should you buy the stock now? |...
Livemint· 2 days agoEmcure Pharma’s IPO saw strong investor interest, with oversubscription rates of 67.87 times....
Vishal Mega Mart weighing confidential filing of IPO papers; fourth after Tata Play, Oyo & Swiggy
CNBC Awaaz· 2 days agoIn May 2018, Kedaara Capital and Partners Group acquired Vishal Mega Mart from TPG
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 2 days agoEmcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a...
Emcure Pharma shares debut with 31% premium over issue price - The Economic Times
The Economic Times· 2 days agoThe company raised Rs 582 crore from anchor investors before the issue launch. Marquee investors who...
Namita Thapar's Emcure Pharma lists at 31% premium on NSE
CNBC Awaaz· 2 days agoThe IPO is managed by Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan...